Release Date: 30/09/14 15:44 Summary: Supplementary Bidders Statement Price Sensitive: Yes Download Document 322.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%